Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Skin Diseases × Vemurafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Neoplasms 3 Skin Neoplasms 1 Skin Diseases 1 Neoplasm Metastasis 1 Colorectal Cancer Metastatic 1

Interventions

binimetinib 2 Aminolevulinic Acid 2 palbociclib 1 ipatasertib 1 encorafenib 1 atezolizumab 1 Vemurafenib 1 Paclitaxel 1 Gonadotropin-Releasing Hormone 1 Docetaxel 1 Dacarbazine 1 Capecitabine 1 Anastrozole 1 AZD9833 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01909453 2026-02-27

COLUMBUS

Pfizer

Phase 3 Completed

921 enrolled 48 charts 1 FDA

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡